Read this topic

Beta-blockers matter in psychiatry because they treat the physical symptoms of anxiety and certain drug side effects, not the underlying mood or thought disorder itself. Propranolol, a lipophilic (fat-soluble) beta-blocker that crosses into the brain easily, is used for performance anxiety, antipsychotic-induced akathisiaAn inner restlessness and urge to keep moving, a common side effect of antipsychotic drugs.Read more → (a distressing inner restlessness with an urge to move), and lithium-induced tremor. For example, imagine a patient about to sit an exam who develops a racing heart and shaking hands from anxiety: propranolol calms these physical symptoms even though it does not touch the underlying worry itself. This split between physical and psychological anxiety symptoms is exactly why beta-blockers are an adjunct, not a primary treatment, for anxiety disorders.

Propranolol blocks beta-adrenergic receptors, reducing sympathetic nervous system output, tremor, palpitations, sweating, which is why it helps performance anxiety, akathisiaAn inner restlessness and urge to keep moving, a common side effect of antipsychotic drugs.Read more →, and lithium-induced tremor. Being lipophilic, it crosses the blood-brain barrierA protective filter of tightly packed cells that limits which substances can pass from the blood into the brain.Read more → readily, unlike hydrophilic (water-soluble) beta-blockers such as atenolol, which act mainly on peripheral, bodily beta receptors. Picture a patient with akathisia after starting an antipsychotic: propranolol reduces the restlessness, whereas atenolol would be a less reliable choice for this centrally mediated symptom. In practice, all beta-blockers require caution in asthma, because beta-2 blockade can trigger bronchospasm, in bradycardia (an abnormally slow heart rate), and in diabetes, because they can mask the warning symptoms of hypoglycaemia (low blood sugar).

• A man with generalised anxiety asks whether propranolol will stop him worrying. What is the most accurate reply about what this drug does and does not do?
• A trainee asks how propranolol differs from atenolol in receptor selectivity. Which description is correct?
• A man with insulin-treated diabetes is considered for propranolol for tremor. Which specific hazard should most influence that decision?
• A man on chlorpromazine is started on propranolol. Which pharmacokinetic consequence should the team anticipate from this combination?

• Benzodiazepines, also used short-term for anxiety, but act on GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more → receptors centrally, unlike propranolol's peripheral and central beta-blockade.
• Atenolol (a hydrophilic beta-blocker), stays mainly outside the brain, unlike propranolol which is lipophilic and crosses into the brain more readily.
• Antimuscarinics such as procyclidine, also treat drug-induced movement side effects, but target parkinsonism and dystoniaInvoluntary muscle contractions causing abnormal, sometimes painful, postures or movements.Read more → rather than akathisiaAn inner restlessness and urge to keep moving, a common side effect of antipsychotic drugs.Read more →.
• SSRISelective serotonin reuptake inhibitor, a common type of antidepressant.Read more → (selective serotonin reuptake inhibitor): treats the psychological core of an anxiety disorder, unlike propranolol which only relieves physical symptoms such as tremor and palpitations.

• The drug does not reliably treat the psychological component.
• Heart-selective blockade describes the comparator drug instead.
• This reverses which component the drug actually helps.
• The physical symptoms do respond to this drug.
• The drug relieves physical symptoms without needing a companion drug.

• Identify the drug, receptor, enzyme or pharmacokinetic change named in the stem.
• Translate it into the immediate mechanism before looking at the options.
• Use timing and the adverse-effect pattern to separate the nearest alternatives.
• Check whether the question asks for mechanism, clinical consequence, monitoring or management.